MedCity News

JANUARY 15, 2025

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report examines the impact of PBMs (specifically CVS Caremark, Express Scripts and Optum Rx) on specialty generic drugs, highlighting substantial price markups by PBMs on medications for cancer, HIV and other conditions. The post Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings appeared first on MedCity News.

Healthcare 120

Healthcare Healthcare Prescription Medical 120

PharmaVoice

JANUARY 14, 2025

Merck looks ahead with an array of cardiometabolic, immunology, neuroscience and ophthalmology pipelines.

113

113

Pharmaceutical Technology

JANUARY 13, 2025

NVIDIA starts 2025 by announcing a trio of partnerships and a research collaboration to boost healthcare sector presence.

Healthcare 110

Healthcare Healthcare 110

PharmaTimes

JANUARY 15, 2025

Funds to accelerate commercialisation and clinical trials of diagnostic tests

Medical 96

Medical 96

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

pharmaphorum

JANUARY 16, 2025

AI start-up Bioptimus takes its funding above $76m as it prepares for the launch of a universal foundation model for pathology later this year.

91

91

MedCity News

JANUARY 13, 2025

Johnson & Johnsons agreement to acquire Intra-Cellular Therapies brings Caplyta, which is projected to become a blockbuster seller across several neurological indications. In other M&A news, GSK and Eli Lilly each struck deals to fill their cancer drug pipelines. The post J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies appeared first on MedCity News.

Prospecting 100

Prospecting Biopharma Pharma 100

Pharmaceutical Technology

JANUARY 10, 2025

Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.

FDA 105

FDA 105

PharmaTimes

JANUARY 14, 2025

First-in-human trial of PTD802 to commence following UK MHRA approval

96

96

pharmaphorum

JANUARY 16, 2025

Santhera will launch its new drug for Duchenne muscular dystrophy in the UK within the next few weeks after getting the green light for NHS coverage

90

90

MedCity News

JANUARY 15, 2025

AI/big data haven’t solved healthcare’s challenges. Despite advancements, systemic barriers persist, but AI offers potential to improve outcomes and efficiency. The post Is Big Data the Cure-all for U.S. Healthcare? appeared first on MedCity News.

Healthcare 102

Healthcare Healthcare 102

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

European Pharmaceutical Review

JANUARY 14, 2025

New long-term data reveals that a modifier gene therapy delivered meaningful visual function improvements for retinitis pigmentosa participants in a Phase I/II clinical trial. A two-year safety and efficacy update from the OCU400 clinical trial showed that 100 percent of treated evaluable participants improved or preserved their visual function compared to untreated eyes at both one and two years.

Safety 85

Safety Medicine Patients Medical 85

Pharmaceutical Technology

JANUARY 16, 2025

Eli Lilly has received approval from the US FDA for Omvoh to treat moderately to severely active Crohn's disease in the adult population.

FDA 105

FDA 105

PharmaTimes

JANUARY 13, 2025

Companies aim to provide new treatments for inflammatory conditions

Pharma 94

Pharma 94

pharmaphorum

JANUARY 16, 2025

Eli Lilly picks up a second FDA approval for IL-23 inhibitor Omvoh in Crohn's disease, but will it kickstart sales growth

FDA 90

FDA Sales 90

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

JANUARY 14, 2025

More than a decade ago, Medtronic announced that a pivotal trial testing its renal denervation system had failed. Though it got approved later, reimbursement has been elusive. All that might change this year. The post Is Medtronic On the Cusp of Rewriting the Story of Renal Denervation? appeared first on MedCity News.

99

99

Healthcare Success

JANUARY 14, 2025

How can healthcare companies use marketing and branding to drive growth and reduce risks in preparation for mergers and acquisitions (M&A)? In this podcast, Victora Shepherd and I explore the critical role of brand integration throughout the M&A lifecycle, with a focus on private equity-backed healthcare companies. We discuss why marketing and brand strategy are often overlooked despite their ability to boost shareholder value by over 23% and improve M&A success rates by 42% [ Source

Marketing 62

Marketing Healthcare Healthcare Media 62

Pharmaceutical Technology

JANUARY 14, 2025

This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.

Pharma 105

Pharma Marketing 105

PharmaTimes

JANUARY 15, 2025

Promising results from mouse study lead to expanded trials

Leads 92

Leads 92

Advertisement

pharmaphorum

JANUARY 10, 2025

An AI algorithm can help detect REM sleep behaviour disorder, which affects millions of people and is a warning signal for neurological diseases.

89

89

MedCity News

JANUARY 12, 2025

Gilead Sciences is acquiring LEO Pharmas oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Morgan Healthcare Conference. The post Gileads New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target appeared first on MedCity News.

Pharma 94

Pharma Healthcare Healthcare Biopharma 94

PharmaVoice

JANUARY 16, 2025

The J.P. Morgan Healthcare Conference has been a focal point for M&A year after year, and after a quiet period, the deals are back on the table.

Leads 74

Leads Healthcare Healthcare 74

Pharmaceutical Technology

JANUARY 12, 2025

Intellia expects to incur charges of $8m associated with the reorganisation, which will likely be incurred in Q1 2025.

95

95

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmaTimes

JANUARY 13, 2025

Survey finds AI to enhance productivity and cut costs in the next 12 months

Pharmaceutical 85

Pharmaceutical 85

pharmaphorum

JANUARY 10, 2025

Ouro launches today with $120m in funding and a plan to develop bispecific antibody-based T cell engagers for autoimmune diseases.

87

87

MedCity News

JANUARY 14, 2025

In an interview, Zelis CEO Amanda Eisel shared her perspective on how the company is solving the problems of a fragmented health financial system to benefit all. The post Improving the Healthcare Financial Experience to Help Care Flow appeared first on MedCity News.

Healthcare 95

Healthcare Healthcare Physicians 95

Pharmaceutical Commerce

JANUARY 17, 2025

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, describes compounding pharmacies efforts in tackling the tirzepatide shortage, and dispels the notion that commercialized and compounded drugs are competing with one another.

Competition 64

Competition Pharma 64

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

Pharmaceutical Technology

JANUARY 14, 2025

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 performance.

88

88

PharmaTimes

JANUARY 16, 2025

Partnership aims to advance Alzheimer's research with innovative tools

77

77

pharmaphorum

JANUARY 15, 2025

A new FTC report claims that pharmacy benefit managers generated $7.3bn by marking up specialty generics used to treat diseases like cancer and HIV.

Management 85

Management 85

MedCity News

JANUARY 10, 2025

Ouro Medicines drugs deplete disease-driving immune cells, allowing the immune system to reset with nave cells that dont attack the body. Monograph Capital founded the startup in partnership with GSK. The post Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System appeared first on MedCity News.

Medicine 87

Medicine Biopharma Pharma 87

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales